GONELLA JACQUES 4
4 · ANTARES PHARMA, INC. · Filed Jun 5, 2018
Insider Transaction Report
Form 4
GONELLA JACQUES
Director10% Owner
Transactions
- Sale
Common Stock
2018-06-05$2.55/sh−100,000$255,000→ 10,529,801 total - Sale
Common Stock
2018-06-04$2.65/sh−100,000$265,000→ 10,629,801 total - Sale
Common Stock
2018-06-01$2.70/sh−56,612$152,852→ 10,729,801 total
Footnotes (1)
- [F1]The sale of common stock reported in this Form 4 was made for estate planning purposes.